We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 0.40 | 0.60 | 0.50 | 0.50 | 0.50 | 654,154 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Surgical,med Instr,apparatus | 11.34M | 264k | 0.0003 | 16.67 | 4.66M |
From Apr 2019 to Apr 2024
TIDMSUN
RNS Number : 0622J
Surgical Innovations Group PLC
26 June 2017
Surgical Innovations Group plc
(the "Group" or the "Company")
AGM Statement
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical technology for minimally invasive surgery, will hold its Annual General Meeting today at 2.00 p.m. at the offices of the Company, Clayton Wood Bank, Leeds LS16 6QZ.
At the meeting Nigel Rogers, Executive Chairman, will make the following statement:
"Trading performance of the Group for the current financial year to date is in line with the Board's expectations. Revenues show strong growth compared with the corresponding period in the prior year, with gross margins delivered within the target range.
"Product innovation continues to be a priority, with focus on the further development of the YelloPort Elite range, our next generation Resposable port access system and the launch of further products to enhance our ranges of retraction and ligation solutions. The overall level of expenditure on product development has been maintained at a similar proportion of revenue as last year, demonstrating our ongoing commitment to innovation.
"The Group continues to be cash generative, with net cash resources building whilst maintaining investment in development, and a modest increase in working capital due to the increased activity level. Overall, the Board is satisfied with progress."
For further information please contact:
Surgical Innovations www.sigroupplc.com Group Plc Nigel Rogers, Executive Tel: 0113 230 7597 Chairman Melanie Ross, COO and CFO WH Ireland Limited (NOMAD Tel: 0113 394 6600 & Broker) Tim Feather Walbrook PR (Financial Tel: 020 7933 8780 or PR & Investor Relations) si@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMSEEFLDFWSEIM
(END) Dow Jones Newswires
June 26, 2017 02:00 ET (06:00 GMT)
1 Year Surgical Innovations Chart |
1 Month Surgical Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
